Lowenstein Sandler represented issuer Celldex Therapeutics, Inc. in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) completed a $150 million public offering of common stock underwritten…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now